Activity of 6-aryl-pyrrolo[2,3-d]pyrimidine-4-amines to Tetrahymena

Farthing, 2006, Nat. Clin. Pract. Gastroenterol. Hepatol., 3, 436, 10.1038/ncpgasthep0557 Fung, 2005, Clin. Ther., 27, 1859, 10.1016/j.clinthera.2005.12.012 Castro, 2006, Hum. Exp. Toxicol., 25, 471, 10.1191/0960327106het653oa Cerecetto, 2010, Pharmaceuticals, 3, 810, 10.3390/ph3040810 Klokouzas, 2003, Int. J. Antimicrob. Agents, 22, 301, 10.1016/S0924-8579(03)00210-3 Townson, 1994, Acta Trop., 56, 173, 10.1016/0001-706X(94)90062-0 Matsushita, 2002, Bioorg. Med. Chem., 10, 855, 10.1016/S0968-0896(01)00355-8 M. Parsons, J.A. Ledbetter, G.L. Schieven, Inhibitors of tyrosine phosphorylation in protozoa as drugs, EP 507256, 1992. Gamo, 2010, Nature, 465, 305, 10.1038/nature09107 Diaz-Gonzalez, 2011, PLoS Neglected Trop. Dis., 5, e1297, 10.1371/journal.pntd.0001297 K. Mensa-Wilmot, Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan protozoal agents, WO 2008066755, 2007. Sauvant, 1999, Chemosphere, 38, 1631, 10.1016/S0045-6535(98)00381-6 Hewitt, 2011, SAR QSAR Environ. Res., 22, 621, 10.1080/1062936X.2011.604100 Schultz, 2010, SAR QSAR Environ. Res., 21, 681, 10.1080/1062936X.2010.528933 Enoch, 2008, Chemosphere, 71, 1225, 10.1016/j.chemosphere.2007.12.011 Bajot, 2011, SAR QSAR Environ. Res., 22, 51, 10.1080/1062936X.2010.528449 Netzeva, 2005, Chemosphere, 61, 1632, 10.1016/j.chemosphere.2005.04.040 Aptula, 2005, Chem. Res. Toxicol., 18, 844, 10.1021/tx049666n Schultz, 1997, Aquat. Toxicol., 39, 267, 10.1016/S0166-445X(97)00031-3 Koubar, 2011, FEMS Microbiol. Lett., 325, 10, 10.1111/j.1574-6968.2011.02402.x W.K. Whitekettle, Control of protozoa and protozoan cysts that harbor Legionella using quaternary ammonium salts, US 20050027010, 2005. P.J. Jakobsen, O. Enger, Treatment of parasite diseases using vitamin K3, WO 2009063044, 2009. Leibowitz, 2010, J. Fish Dis., 33, 473, 10.1111/j.1365-2761.2010.01143.x Muto, 2011, Cent. Eur. J. Biol., 6, 99, 10.2478/s11535-010-0100-7 Hegyesi, 1992, Acta Microbiol. Hung., 39, 289 Nilsson, 1986, Protoplasma, 135, 1, 10.1007/BF01277047 Wu, 1996, Arch. Toxicol., 70, 850, 10.1007/s002040050349 Kaczanowski, 1991, Exp. Cell Res., 195, 330, 10.1016/0014-4827(91)90381-4 Csaba, 2004, Cell Biol. Int., 28, 491, 10.1016/j.cellbi.2004.04.002 L. Chiu, Pharmaceutical compositions containing protein kinase B inhibitors and epidermal growth factor receptor tyrosine kinase inhibitors for treating cancer, CN 101653606, 2008. Chen, 2004, J. Microbiol. Methods, 59, 233, 10.1016/j.mimet.2004.07.003 Kovacs, 1992, Cell Biochem. Funct., 10, 267, 10.1002/cbf.290100410 Hans, 2001, Oncogene, 20, 3021, 10.1038/sj.onc.1204326 Li, 2009, Cell Biochem. Funct., 27, 364, 10.1002/cbf.1583 Nakashima, 1999, J. Biol. Chem., 274, 9976, 10.1074/jbc.274.15.9976 Bartholomew, 2008, Purinergic Signalling, 4, 171, 10.1007/s11302-007-9052-4 Kaspersen, 2011, Eur. J. Med. Chem., 46, 6002, 10.1016/j.ejmech.2011.10.012 Otterholt, 2011, Water Res., 45, 2527, 10.1016/j.watres.2011.02.008 Bain, 2007, Biochem. J., 408, 297, 10.1042/BJ20070797 Sørum, 2010, Magn. Reson. Chem., 48, 244, 10.1002/mrc.2560 X. Cai, C. Qian, S. Gould, Fused bicyclic pyrimidines as PTK inhibitors containing a zinc binding moiety, WO 2008033745, 2007. Toja, 1987, Synthesis, 272, 10.1055/s-1987-27913 Caravatti, 2001, ACS Symposium Series, 796, 231, 10.1021/bk-2001-0796.ch014 Schemarova, 2007, Tsitologiya, 49, 156 Vaid, 2006, J. Biol. Chem., 281, 27126, 10.1074/jbc.M601914200 Guergnon, 2006, Apoptosis, 11, 1263, 10.1007/s10495-006-7702-6 Pascuccelli, 1999, Mol. Biochem. Parasitol., 102, 21, 10.1016/S0166-6851(99)00076-6 Gonda, 1999, J. Cell Sci., 112, 3619, 10.1242/jcs.112.21.3619 Hirano-Ohnishi, 1989, J. Biochem., 105, 858, 10.1093/oxfordjournals.jbchem.a122766 Hassenzahl, 2001, J. Comp. Physiol. A., 187, 171, 10.1007/s003590100185 Arslanyolu, 2007, J. Appl. Biol. Sci., 1, 1 Bamdad, 1999, FEBS Lett., 456, 389, 10.1016/S0014-5793(99)00978-3 Iida, 1979, Comp. Biochem. Physiol. C, 63C, 381, 10.1016/0306-4492(79)90090-X Takada, 2004, Drug Metab. Dispos., 32, 1272, 10.1124/dmd.104.000497